Page last updated: 2024-08-17

mephenoxalone and Cutaneous T-Cell Lymphoma

mephenoxalone has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YC; Wu, YH	1

Other Studies

1 other study(ies) available for mephenoxalone and Cutaneous T-Cell Lymphoma

Article	Year
Linear Folliculotropic CD30-Positive Lymphomatoid Drug Reaction. The American Journal of dermatopathology, 2017, Volume: 39, Issue:5 Topics: Biopsy, Needle; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Facial Dermatoses; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphocytes; Lymphoma, T-Cell, Cutaneous; Middle Aged; Oxazoles; Risk Assessment; Skin Neoplasms; Withholding Treatment	2017

Article

Year

Linear Folliculotropic CD30-Positive Lymphomatoid Drug Reaction.

The American Journal of dermatopathology, 2017, Volume: 39, Issue:5

Topics: Biopsy, Needle; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Facial Dermatoses; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphocytes; Lymphoma, T-Cell, Cutaneous; Middle Aged; Oxazoles; Risk Assessment; Skin Neoplasms; Withholding Treatment

2017